Features

Management of Oligometastatic PCa

More and more cases of oligometastatic PCa are being diagnosed as a result of advances in molecular imaging, but clinical trial data about the best ...

Avoid Biopsy for Elevated PSA?

Multiparametric magnetic resonance imaging in conjunction with transrectal ultrasound-guided biopsy improves discrimination between clinically significant and insignificant prostate tumors and can spare patients unnecessary biopsies.

3D Printed Prostates Could Improve RP

New technique uses silicone-based polymer inks to create prostate models with the tactile sensation, pliability, and texture of a real prostate.

Outpatient Transperineal Prostate Biopsy

The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B.

PET/CT for Prostate Cancer

Novel PET radiotracers have shown great potential in the early diagnosis and staging of PCa, detection of post-treatment recurrence, and monitoring of metastases not previously ...

RP vs Radiation for High-Risk PCa

Physicians who treat patients with high-risk prostate cancer remain uncertain as to the optimal treatment approach, in part due to difficulty in interpreting study data.

New PCa Grading System Embraced

Endorsed by the International Society of Urological Pathology in 2014, the 5-tier Gleason grade group system is used routinely today in pathology reports and physician ...

Overuse of PCa Scans May Be Easing

Efforts by physician groups in recent years to discourage inappropriate use of radiologic imaging for the initial staging of men with newly diagnosed low-risk disease ...

The Role of MRI in Prostate Cancer Management

An interview with Ashutosh K. Tewari, MBBS, MCh

Latest Prostate Cancer News

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Men with low-risk PCa who underwent partial gland ablation with vascular-targeted photodynamic therapy were less likely than those on AS to require radical treatment.

Node-Positive Prostate Cancer on the Rise

Node-Positive Prostate Cancer on the Rise

The percentage of prostate cancer patients with positive lymph nodes increased from 2.4% in 2010 to 4.7% in 2014.

BPH, Cancers Linked to Peyronie's Disease

BPH, Cancers Linked to Peyronie's Disease

Men with Peyronie's disease have elevated risks of benign prostatic hyperplasia, prostatitis, and testis and prostate cancer, new studies reveal.

Testosterone Therapy Safe Despite Prostate Cancer History

Testosterone Therapy Safe Despite Prostate Cancer History

Findings from the largest study to date examining the effect of TRT in prostate cancer patients build on previous evidence showing that the treatment does not affect disease progression risk.

Incontinence, Impotence Risk After RP Linked to Metabolic Syndrome

Incontinence, Impotence Risk After RP Linked to Metabolic Syndrome

At 1 year post-op, patients with MetS prior to prostate surgery had a significantly lower continence rate than those without MetS (75.4% vs 82.6%).

Clinical Variables Predict Radiographic Progression in mCRPC

Clinical Variables Predict Radiographic Progression in mCRPC

Extent of disease and change in PSA were the strongest predictors of disease progression in men with chemotherapy-naïve mCRPC treated with abiraterone.

Focal vs Total PCa Cryoablation Better for Sexual Function

Focal vs Total PCa Cryoablation Better for Sexual Function

Oncologic outcomes are similar for focal and total cryoablation for localized prostate cancer, but patients report significantly better sexual function after focal cryoablation.

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

Men on active surveillance for prostate cancer who had a negative confirmatory biopsy experienced an 88% decreased risk of progression to treatment.

Prostate Cancer Recurrence Risk Lower With Anterior Tumors

Prostate Cancer Recurrence Risk Lower With Anterior Tumors

Following laparoscopic radical prostatectomy, men with posterior index tumors had 76% increased risk of biochemical recurrence vs those with anterior prostate tumors.

Gleason Score at Surgical Margin Affects BCR Risk

Gleason Score at Surgical Margin Affects BCR Risk

Gleason score at the margin can better stratify biochemical recurrence-free rates, according to study findings.

AS May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer

AS May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer

Men with Gleason 6 and Gleason 3+4 prostate cancer who undergo radical prostatectomy after a period on active surveillance have similar surgical outcomes.

Novel Blood Test Improves Detection of High-Grade Prostate Cancer

Novel Blood Test Improves Detection of High-Grade Prostate Cancer

IsoPSA can correctly rule out high-grade prostate cancer 93% of the time and thus has the potential to reduce the number of unnecessary prostate biopsies.

Optimal Post-Radical Prostatectomy Follow-up Schedule Proposed

Optimal Post-Radical Prostatectomy Follow-up Schedule Proposed

Investigators suggest PSA testing frequencies based on post-operative baseline PSA.

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk

Findings show small increased risk with white wine, decreased risk with red wine

Predictors of Adverse Pathology After Prostate Cancer Surgery ID'd

Predictors of Adverse Pathology After Prostate Cancer Surgery ID'd

High PSA levels and larger number of positive biopsy cores are associated with positive surgical margins and extracapsular extension/seminal vesicle invasion after radical prostatectomy.

Sign up for free e-Newsletters